NO965556L - Trippelkombinasjon mot HIV - Google Patents

Trippelkombinasjon mot HIV

Info

Publication number
NO965556L
NO965556L NO965556A NO965556A NO965556L NO 965556 L NO965556 L NO 965556L NO 965556 A NO965556 A NO 965556A NO 965556 A NO965556 A NO 965556A NO 965556 L NO965556 L NO 965556L
Authority
NO
Norway
Prior art keywords
against hiv
triple combination
combination against
aids
lamivudine
Prior art date
Application number
NO965556A
Other languages
English (en)
Other versions
NO965556D0 (no
Inventor
Paulus Aloysius Maria Stoffels
Koenraad Jozef Lodewijk
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO965556L publication Critical patent/NO965556L/no
Publication of NO965556D0 publication Critical patent/NO965556D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse vedrører en terapeutisk kombinasjon omfattende zidovudin, lamivudin og lovi- rid for behandling av "Human Immonodeficiency Virus» (AIDS) eller AIDS-relatert kompleks (ARC).
NO965556A 1994-07-01 1996-12-23 Trippelkombinasjon mot HIV NO965556D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201897 1994-07-01
PCT/EP1995/002462 WO1996001110A2 (en) 1994-07-01 1995-06-23 Anti-hiv triple combination

Publications (2)

Publication Number Publication Date
NO965556L true NO965556L (no) 1996-12-23
NO965556D0 NO965556D0 (no) 1996-12-23

Family

ID=8217000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965556A NO965556D0 (no) 1994-07-01 1996-12-23 Trippelkombinasjon mot HIV

Country Status (25)

Country Link
EP (1) EP0768881B1 (no)
JP (1) JP2945481B2 (no)
KR (1) KR100218495B1 (no)
CN (1) CN1091599C (no)
AP (1) AP9600896A0 (no)
AT (1) ATE218867T1 (no)
AU (1) AU693911B2 (no)
BG (1) BG101175A (no)
BR (1) BR9508201A (no)
CA (1) CA2193489A1 (no)
CZ (1) CZ375596A3 (no)
DE (1) DE69527066T2 (no)
EE (1) EE9600180A (no)
FI (1) FI965292A (no)
HU (1) HUT77720A (no)
IL (1) IL114415A0 (no)
MX (1) MX9700044A (no)
MY (1) MY130597A (no)
NO (1) NO965556D0 (no)
OA (1) OA10341A (no)
PL (1) PL317891A1 (no)
SK (1) SK168196A3 (no)
TW (1) TW401303B (no)
WO (1) WO1996001110A2 (no)
ZA (1) ZA955471B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4088697A (en) * 1996-08-26 1998-03-19 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
IL148801A0 (en) 1999-09-24 2002-09-12 Janssen Pharmaceutica Nv Antiviral compositions
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US9044509B2 (en) 2006-02-03 2015-06-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibition of HIV infection through chemoprophylaxis
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
US8481554B2 (en) 2009-05-27 2013-07-09 Hetero Research Foundation Solid oral dosage forms of lamivudine
US20210128554A1 (en) * 2016-12-23 2021-05-06 Temple University - Of The Commonwealth System Of Higher Education Anti-flaviviridae activity of anti-retroviral non-nucleoside (nnrtis) and nucleoside reverse transcriptase inhibitors (nnrtis)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279262B6 (sk) * 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je

Also Published As

Publication number Publication date
ZA955471B (en) 1996-12-30
MX9700044A (es) 1997-04-30
OA10341A (en) 1997-10-07
WO1996001110A3 (en) 1996-02-22
AU2924895A (en) 1996-01-25
CN1091599C (zh) 2002-10-02
BR9508201A (pt) 1997-11-11
HUT77720A (hu) 1998-07-28
DE69527066D1 (de) 2002-07-18
ATE218867T1 (de) 2002-06-15
IL114415A0 (en) 1995-10-31
TW401303B (en) 2000-08-11
PL317891A1 (en) 1997-04-28
AU693911B2 (en) 1998-07-09
JPH09507858A (ja) 1997-08-12
AP9600896A0 (en) 1997-01-31
HU9603627D0 (en) 1997-02-28
CA2193489A1 (en) 1996-01-18
EP0768881A2 (en) 1997-04-23
KR100218495B1 (en) 1999-09-01
CN1151697A (zh) 1997-06-11
FI965292A0 (fi) 1996-12-31
CZ375596A3 (en) 1997-04-16
DE69527066T2 (de) 2003-02-13
NO965556D0 (no) 1996-12-23
JP2945481B2 (ja) 1999-09-06
SK168196A3 (en) 1997-05-07
BG101175A (en) 1997-08-29
EE9600180A (et) 1997-06-16
FI965292A (fi) 1996-12-31
WO1996001110A2 (en) 1996-01-18
MY130597A (en) 2007-07-31
EP0768881B1 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
AU2452288A (en) Nucleoside derivatives useful in treating retroviral infections
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
AU6924796A (en) 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DK92788D0 (da) Ny medicinsk anvendelse
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
AU8090087A (en) The use of 3-deoxy-thymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
KR970702919A (ko) 재조합형의 인간면역부전바이러스 담체 및 그 제조방법(Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same)
NO965556L (no) Trippelkombinasjon mot HIV
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
IL104323A0 (en) Hemoregulatory peptides
NO981564D0 (no) Terapeutisk administrering av hemoglobin ved hjertestans
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
HK1010985A1 (en) The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
AP9801368A0 (en) Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AP9901681A0 (en) Antiviral composition containing oxidized inositol, sodium sulfite, pyrocatechol and copper sulfate.
MX9706942A (es) Compuestos quimicos.
ZA981198B (en) Treatment of hiv positive patients